A new delivery particle developed at MIT could make mRNA vaccines more effective and potentially lower the cost per vaccine ...

A new lipid nanoparticle could make mRNA vaccines more powerful and potentially lower the cost per vaccine dose.

Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

The team used the AMG1541 LNP to deliver an mRNA influenza vaccine in mice. They compared this vaccine’s effectiveness to a flu vaccine made with the lipid SM-102, which is FDA-approved and was used ...

The approach is “very exciting,” but one expert says a lot more research is needed, especially around safety, before clinical ...

Traumatic brain injury (TBI) remains one of the most pressing public health challenges, leaving millions with lasting ...

A CRISPR-based gene therapy showed improvement in lipids in difficult-to-treat patients, but one study raised flags after a death last month in a trial of an unrelated gene therapy.

After forming from a merger hashed out over plates of tacos about a year ago, nChroma Bio is laying off staff and ...

Dublin, Oct. 24, 2025 (GLOBE NEWSWIRE) -- The "United States Lipid Nanoparticle Market Report by Type, Application, End Use, States and Company Analysis, 2025-2033" report has been added to ...

A recent study published in ACS Nano explored a novel strategy to reprogram the liver’s immune environment and generate an antitumor response against metastatic pancreatic cancer. Image Credit: ...